Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-143040
Filing Date
2016-09-28
Accepted
2016-09-28 17:29:01
Documents
2
Period of Report
2016-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11312
2 POA DOCUMENT poa.txt EX-24.4_677001 4202
  Complete submission text file 0001209191-16-143040.txt   16923
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
Cantley Lewis Clayton Jr. (Reporting) CIK: 0001581950 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 161907838